Filed: 5/15/2024ACC: 0001420506-24-000871
📋 What this filing means
SILVERARC CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 77 equity positions with a total reported market value of $360.05M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
77
Positions
$360.05M
Total AUM (reported)
48.95M
Total Shares
Allocation by class
COM$261.43M72.6%
COM NEW$57.80M16.1%
COM STK$11.73M3.3%
SHS$7.62M2.1%
CL A ORD SHS$5.20M1.4%
SPONSORED ADS$3.70M1.0%
CALL$3.43M1.0%
Portfolio Concentration
Top 3$60.19M16.7%
4–10$88.86M24.7%
11–25$112.35M31.2%
Rest$98.66M27.4%
Top 3 weight
16.7%
Top 10 weight
41.4%
Voting Authority Distribution
Total shares with voting rights: 48.95M
Sole
Full voting authority
48.95M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole77
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings77
Rows:
MERUS N V
SOLEShares566.29K
TypeSH
Market value$25.50M
7.08%
Sole
566.29K
Shared
0.00
None
0.00
SOLID BIOSCIENCES INC
SOLEShares1.33M
TypeSH
Market value$17.65M
4.90%
Sole
1.33M
Shared
0.00
None
0.00
MORPHIC HLDG INC
SOLEShares483.97K
TypeSH
Market value$17.04M
4.73%
Sole
483.97K
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares1.11M
TypeSH
Market value$15.30M
4.25%
Sole
1.11M
Shared
0.00
None
0.00
MERSANA THERAPEUTICS INC
SOLEShares2.97M
TypeSH
Market value$13.30M
3.69%
Sole
2.97M
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares299.32K
TypeSH
Market value$12.56M
3.49%
Sole
299.32K
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
SOLEShares489.30K
TypeSH
Market value$12.49M
3.47%
Sole
489.30K
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares157.75K
TypeSH
Market value$11.85M
3.29%
Sole
157.75K
Shared
0.00
None
0.00
C4 THERAPEUTICS INC
SOLEShares1.44M
TypeSH
Market value$11.73M
3.26%
Sole
1.44M
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares190.56K
TypeSH
Market value$11.63M
3.23%
Sole
190.56K
Shared
0.00
None
0.00
POSEIDA THERAPEUTICS INC
SOLEShares3.60M
TypeSH
Market value$11.47M
3.19%
Sole
3.60M
Shared
0.00
None
0.00
AKERO THERAPEUTICS INC
SOLEShares399.95K
TypeSH
Market value$10.10M
2.81%
Sole
399.95K
Shared
0.00
None
0.00
PERSPECTIVE THERAPEUTICS INC
SOLEShares8.11M
TypeSH
Market value$9.65M
2.68%
Sole
8.11M
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
SOLEShares183.78K
TypeSH
Market value$7.96M
2.21%
Sole
183.78K
Shared
0.00
None
0.00
ALPINE IMMUNE SCIENCES INC
SOLEShares199.02K
TypeSH
Market value$7.89M
2.19%
Sole
199.02K
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares508.59K
TypeSH
Market value$7.63M
2.12%
Sole
508.59K
Shared
0.00
None
0.00
GOSSAMER BIO INC
SOLEShares6.13M
TypeSH
Market value$7.23M
2.01%
Sole
6.13M
Shared
0.00
None
0.00
MACROGENICS INC
SOLEShares478.08K
TypeSH
Market value$7.04M
1.95%
Sole
478.08K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares1.04M
TypeSH
Market value$6.97M
1.93%
Sole
1.04M
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares561.18K
TypeSH
Market value$6.66M
1.85%
Sole
561.18K
Shared
0.00
None
0.00
KODIAK SCIENCES INC
SOLEShares1.24M
TypeSH
Market value$6.52M
1.81%
Sole
1.24M
Shared
0.00
None
0.00
VERACYTE INC
SOLEShares280.77K
TypeSH
Market value$6.22M
1.73%
Sole
280.77K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares127.83K
TypeSH
Market value$5.98M
1.66%
Sole
127.83K
Shared
0.00
None
0.00
OLEMA PHARMACEUTICALS INC
SOLEShares515.32K
TypeSH
Market value$5.83M
1.62%
Sole
515.32K
Shared
0.00
None
0.00
HELIX ACQUISITION CORP II
SOLEShares500K
TypeSH
Market value$5.20M
1.44%
Sole
500K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MERUS N VSOLE | COM | 566.29K | SH | $25.50M 7.08% | 566.29K | 0.00 | 0.00 |
SOLID BIOSCIENCES INCSOLE | COM NEW | 1.33M | SH | $17.65M 4.90% | 1.33M | 0.00 | 0.00 |
MORPHIC HLDG INCSOLE | COM | 483.97K | SH | $17.04M 4.73% | 483.97K | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 1.11M | SH | $15.30M 4.25% | 1.11M | 0.00 | 0.00 |
MERSANA THERAPEUTICS INCSOLE | COM | 2.97M | SH | $13.30M 3.69% | 2.97M | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 299.32K | SH | $12.56M 3.49% | 299.32K | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCSOLE | COM | 489.30K | SH | $12.49M 3.47% | 489.30K | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 157.75K | SH | $11.85M 3.29% | 157.75K | 0.00 | 0.00 |
C4 THERAPEUTICS INCSOLE | COM STK | 1.44M | SH | $11.73M 3.26% | 1.44M | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 190.56K | SH | $11.63M 3.23% | 190.56K | 0.00 | 0.00 |
POSEIDA THERAPEUTICS INCSOLE | COM | 3.60M | SH | $11.47M 3.19% | 3.60M | 0.00 | 0.00 |
AKERO THERAPEUTICS INCSOLE | COM | 399.95K | SH | $10.10M 2.81% | 399.95K | 0.00 | 0.00 |
PERSPECTIVE THERAPEUTICS INCSOLE | COM | 8.11M | SH | $9.65M 2.68% | 8.11M | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCSOLE | COM | 183.78K | SH | $7.96M 2.21% | 183.78K | 0.00 | 0.00 |
ALPINE IMMUNE SCIENCES INCSOLE | COM | 199.02K | SH | $7.89M 2.19% | 199.02K | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 508.59K | SH | $7.63M 2.12% | 508.59K | 0.00 | 0.00 |
GOSSAMER BIO INCSOLE | COM | 6.13M | SH | $7.23M 2.01% | 6.13M | 0.00 | 0.00 |
MACROGENICS INCSOLE | COM | 478.08K | SH | $7.04M 1.95% | 478.08K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 1.04M | SH | $6.97M 1.93% | 1.04M | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 561.18K | SH | $6.66M 1.85% | 561.18K | 0.00 | 0.00 |
KODIAK SCIENCES INCSOLE | COM | 1.24M | SH | $6.52M 1.81% | 1.24M | 0.00 | 0.00 |
VERACYTE INCSOLE | COM | 280.77K | SH | $6.22M 1.73% | 280.77K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 127.83K | SH | $5.98M 1.66% | 127.83K | 0.00 | 0.00 |
OLEMA PHARMACEUTICALS INCSOLE | COM | 515.32K | SH | $5.83M 1.62% | 515.32K | 0.00 | 0.00 |
HELIX ACQUISITION CORP IISOLE | CL A ORD SHS | 500K | SH | $5.20M 1.44% | 500K | 0.00 | 0.00 |
Page 1 of 4